Contrast Media Injectors Market
Contrast Media Injectors Infusing New Trends in the Healthcare Sector. FMI Detects its Effect in All Major Economies.
Contrast Media Injectors Market Analysis by Product Type, by End User, and by Region | Forecast for 2023 to 2033
Contrast Media Injectors Market Snapshot (2023 to 2033)
The global contrast media injectors market was valued at US$ 1.5 Billion in 2022 and is expected to reach US$ 3 Billion by 2033, finds Future Market Insights (FMI) in a recent market survey.
The growing prevalence of trauma cases and the rising number of radiology procedures using contrast media are the primary factors boosting the demand for contrast media injectors. Also, the increase in the geriatric population and the growth of diagnostic imaging centers have strengthened the market for contrast media injectors.
The use of contrast media in radiology to enhance image quality while diagnosing a tumor is projected to develop significantly in the future. All these factors, along with the increasing prevalence of cancer worldwide, are expected to drive market growth further in the projected period.
The contrast media injectors market holds nearly 4.2% market share of the diagnostic imaging market, which was US$ 36.1 Billion in 2021. In addition, increasing awareness among physicians regarding patient safety during contrast media insertion is forcing market players to upgrade safety parameters in contrast media injectors.
Strengthening the supply chain, particularly in regions such as the Asia Pacific and the Middle East, and Africa, is the key focus area for players in this market. There is an increasing necessity to ensure the supply of the best contrast media products, as quality is of utmost importance to end users.
Governments are providing ample funding for diagnostic imaging services, with funding increasing each year substantially for healthcare facilities to adopt modern equipment. The market is also expanding owing to increasing applications of diagnostic imaging in the field of radiology and image-guided minimally invasive surgery.
|
Data Points |
Market Insights |
|
Market Value 2022 |
USD 1.5 Billion |
|
Market Value 2023 |
USD 1.6 Billion |
|
Market Value 2033 |
USD 3.0 Billion |
|
CAGR 2023 to 2033 |
6.6% |
|
Key Players |
The key players are Bayer AG, NemotoKyorindo Co. Ltd., Mallinckrodt, Bracco Imaging, Ulrich GmBh, Guerbet SA, Medtron AG, |
|
Share of Top 5 Countries |
58.1% |
The rising BPS value for the contrast media injectors market can be ascribed to the growing demand for minimally invasive procedures. There has also been a significant increase in finance and grants necessary to improve existing product lines.
The global contrast media injectors market is influenced by quality and safety regulations and licensure. Macroeconomic, regulatory, and industrial variables all have an impact on the market.
The Imaging Bulk Package (IBP), a multi-patient, multi-dose compliant contrast medium, was approved by the FDA for POC usage in the CT suite. It was created to improve safety and workflow while reducing risk and preserving compliance with multi-dose CT contrast media as a key market development factor.
Other market segments, on the other hand, are expected to perform objectively over the first half of the forecast period. Later these are expected to achieve lucrative growth prospects in the second half, especially with the development of CT and MRI contrasting agents.
Let us know your requirement to get
100% FREE customization
Global Contrast Media Injectors Market Historical Analysis (2016 to 2022) Vs. Forecast Outlook (2023 to 2033)
Sales of contrast media injectors registered a CAGR of 5.5% between 2016 and 2022. Covid-19 had a significant influence on the contrast media injector market in 2020, with sales dropping by roughly 20%. By 2022, the market is expected to return to its previous highs.
The primary factors boosting the market are the rising number of radiology procedures using contrast media for reducing human error and increasing patient safety. So, healthcare professionals make it compulsory to undergo radiological testing with contrast media to come on any closing statement for any disease.
Most hospitals and ambulatory surgical centers do the radiological procedures using contrast media for patients with chronic diseases, accidents, and autoimmune diseases. Currently, some advanced contrast media injectors are available in the market that can be connected to the hospital’s IT system. It helps to directly access data from the hospital information systems (HIS) or electronic medical record (EMR) systems to adjust the dose.
This has created opportunities for leading players to come up with innovative ideas and bloom the market. Considering this, FMI expects the global contrast media injectors market to register a CAGR of 6.6% through 2033.
Major Factors Restraining the Demand for Contrast Media Injectors
The worldwide revenue growth of the contrast media injectors market is projected to be hampered by adverse consequences associated with air emboli. Air emboli formation, which arises from a major air infusion that generates an airlock in the pulmonary artery, causes blood pressure to drop quickly. It is followed by cardiovascular collapse, which is a major problem encountered during contrast media injection.
The rising cost of contrast media injectors is likely to restrict market growth throughout the forecast period, as many hospitals are unable to purchase them. Also, the demand for creative advancements, in contrast, to media injectors, has resulted in a significant increase in the price of CT and MRI injectors. Such developments have limited the sale of contrast media injectors to facilities without ample funding.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCategory-wise Insights
Demand for CT Injectors continues Gaining Traction
By Product, CT Injectors are anticipated to hold the maximum share of 43.0% in 2022 owing to their ability to aid in 3D visual reconstruction.
CT injectors are used to inject iodine-based contrast media for computed tomography procedures. The adoption of CT injectors for the insertion of contrast media for various procedures such as X-ray and ultrasound is increasing. CT injectors are used to enhance image quality while also increasing patient safety.
The hospitals segment Projected Maximum Growth in the Sales of Contrast Media Injectors
Among the end-user verticals, the Hospital pharmacies segment is anticipated to hold the maximum share of 49.4% in 2022.
Hospitals have access to modern medical technology, and their infrastructure is capable of delivering high-quality care for any disease condition. Hospitals are expected to account for a significant portion of the market, as the majority of people prefer to visit hospitals for any health-related issue.
Additionally, the expanding number of hospitals and increased accessibility in emerging countries are expected to provide profitable prospects for this segment to grow further.
Comparative View of Adjacent Contrast Media Injectors Market
Contrast Media Injectors Market:
|
Attributes |
Contrast Media Injectors Market |
|
CAGR (2023 to 2033) |
6.6% |
|
Market Value (2023) |
US$ 1.6 Billion |
|
Growth Factor |
Growing cases of radiology procedures during trauma cases. |
|
Future Opportunities |
The increasing popularity of minimally invasive procedures in almost all diseases. |
|
Market Trends |
Manufacturers are coming up with new products to remain competitive. |
Therapeutic Respiratory Devices Market:
|
Attributes |
Therapeutic Respiratory Devices Market |
|
CAGR (2023 to 2033) |
8.7% |
|
Market Value (2023) |
US$ 24.2 Billion |
|
Growth Factor |
Growing cases of COPD, Asthma, TB, and others. |
|
Future Opportunities |
An increasing percentage of aged people in the western economies. |
|
Market Trends |
Manufacturers are collaborating with NGOs and Government bodies. |
Intraosseous Infusion Devices Market:
|
Attributes |
Intraosseous Infusion Devices Market |
|
CAGR (2023 to 2033) |
6.9% |
|
Market Value (2023) |
US$ 4.4 Billion |
|
Growth Factor |
Rising number of casualty cases in the hospitals. |
|
Future Opportunities |
Improving awareness of patients as well as healthcare professionals. |
|
Market Trends |
The long-term partnership of product vendors and military healthcare facilities. |
A unified Market Research Subscription Platform, built for today's disparate research needs.
Country-wise Insights
|
Countries |
CAGR (2023 to 2033) |
|
The USA |
6.8% |
|
The United Kingdom |
6.4% |
|
Germany |
6.3% |
|
China |
7.8% |
|
India |
5.4% |
The United States Dominates the Contrast Media Injectors Market
|
Attributes |
Details |
|
Market Size (2033) |
US$ 967.4 Million |
|
Market Absolute Dollar Growth (US$ Million/Billion) |
US$ 467.3 Million |
The USA is estimated to account for around 89.5% of the North American contrast media injectors market in 2023.
The USA dominates the contrast media injectors market owing to favorable reimbursement policies and a higher percentage of the aging population in the country. Further, the rise in the regulatory approval of an increasing number of contrast agents and increasing government funding have strengthened the emerging trends.
The healthcare business in the USA is one of the well-known markets in terms of product accessibility and innovations. Trauma cases are also one of the major reasons driving the demand for contrast media injectors in Hospitals in the USA. According to the American Association for the Surgery of Trauma reported data, in 2020, trauma accounted for nearly 40 Million homicide and suicide deaths each year.
Furthermore, the presence of more IT-enabled solutions in USA Hospitals can provide additional potential development prospects for this market.
Germany is the Leading Contrast media injectors Market in European Region
|
Attributes |
Details |
|
Market Size (2033) |
US$ 202.9 Million |
|
Market Absolute Dollar Growth (US$ Million/Billion) |
US$ 92.3 Million |
Germany is estimated to account for 25.8% of the Western Europe contrast media injectors market in 2022, as a result of its well-established healthcare infrastructure.
An increase in the incidence of chronic illnesses as a consequence of changing lifestyles has strengthened the German contrast media injectors market. Furthermore, the demand for contrast media injectors in Germany is getting fueled by rising demand for minimally invasive treatments and medical tourism.
China to Outcompete All Other Countries in the Production of Contrast Media Injectors
|
Attributes |
Details |
|
Market Size (2033) |
US$ 192.3 Million |
|
Market Absolute Dollar Growth (US$ Million/Billion) |
US$ 101.6 Million |
The contrast media injectors market in China is estimated to be worth 53.1% market share in 2022 in the Asia Pacific excluding Japan (APEJ) market. The market in China is further projected to witness the highest growth rate owing to increased Research and Development (R&D) investments and a favorable demographic scenario.
The growing demand for quality healthcare facilities and the high patient population with chronic diseases are the major factors driving the sales of contrast media injectors. Being an emerging country, China is also expected to provide enormous opportunities for manufacturers to expand their business in this sector.
According to a report by WHO, in 2020, non-communicable diseases accounted for 80% of total deaths and 70% of disability-adjusted life years lost in China. This is a situation where diagnosis plays an important role and is expected to lead the contrast media injectors market growth in China.
Sales of Contrast Media Injectors in India to Rise During the Later Part of the Forecast Period
|
Attributes |
Details |
|
Market Size (2033) |
US$ 42.5 Million |
|
Market Absolute Dollar Growth (US$ Million/Billion) |
US$ 17.5 Million |
The contrast media injectors market in India is expected to have a nearly 15.0% share in the Asia Pacific market in the years following 2022.
The expansion of this sector is being driven by increased government assistance to boost healthcare infrastructure and medical service delivery. Besides, increased investment in the Indian radiology industry and increased emphasis on market participants have strengthened the market over the years.
India is anticipated to grow at an impressive rate as patients are searching for low-cost diagnoses with outpatient imaging. Demand for outpatient imaging is continuously increasing because diagnostic centers offer more relaxed, personalized service and liberties which are more accepted by the patient. CT and MRI growth have been exceptional and are increasing at a rate of about 200% over the past 10 years.
Competitive Landscape
Companies operating in the contrast media injectors market are getting competitive with the entry of many new players in the last few years. Moreover, the existing players are involved in a number of strategic alliances to expand their distribution network and remain competitive against their rivals.
The contrast media injector’s market players are trying out every possible mode of organic and inorganic growth to sustain themselves in the market. New product launches accelerate the injector manufacturer’s strategy to capitalize on market trends and capture a significant share of the market.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2016 to 2022 |
|
Historical Data Available for |
2023 to 2033 |
|
Market Analysis |
USD Billion for Value and Units for Volume |
|
Key Countries Covered |
The USA, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Italy, Spain, Poland, Russia, Greater China, Japan, India, Australia, New Zealand, GCC Countries, South Africa |
|
Key Segments Covered |
Product Type, End User, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Contrast Media Injectors Market by Category
By Product Type:
- CT Injectors
- MRI Injectors
- Cardio Injectors
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Diagnostics Centers
- Others
By Region:
- North America
- Latin America
- Eastern Europe
- Western Europe
- Asia Pacific excluding Japan
- Japan
- Middle East and Africa (MEA)
Frequently Asked Questions
The global contrast media injectors market is to grow at 6.6% during the forecast period.
The global contrast media injectors market is predicted to be valued at US$ 3 billion by 2033.
The global contrast media injectors market was valued at US$ 1.5 billion in 2022.
The USA accounts for 32.5% of the global revenue share in the year 2023.
China is predicted to witness the highest CAGR of 7.8% in the contrast media injectors market.
Table of Content
1. Executive Summary | Contrast Media Injectors Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ million) & Volume (Units) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Product, 2017 to 2022
5.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
5.3.1. CT Injectors
5.3.2. MRI Injectors
5.3.3. Cardio Injectors
5.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By End User, 2017 to 2022
6.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. Diagnostics Centers
6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Region, 2017 to 2022
7.3. Current Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. APEJ
7.3.6. Japan
7.3.7. Middle East and Africa (MEA)
7.4. Market Attractiveness Analysis By Region
8. North America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
8.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. The USA
8.2.1.2. Canada
8.2.2. By Product
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
9.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By End User
9.4. Key Takeaways
10. Western Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. France
10.2.1.2. Germany
10.2.1.3. Italy
10.2.1.4. Spain
10.2.1.5. The United Kingdom
10.2.1.6. Rest of Western Europe
10.2.2. By Product
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By End User
10.4. Key Takeaways
11. Eastern Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Russia
11.2.1.2. Poland
11.2.1.3. Rest of Eastern Europe
11.2.2. By Product
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By End User
11.4. Key Takeaways
12. APEJ Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Greater China
12.2.1.2. India
12.2.1.3. ANZ
12.2.1.4. Rest of APEJ
12.2.2. By Product
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By End User
12.4. Key Takeaways
13. Japan Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.2. By Product
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By End User
13.4. Key Takeaways
14. MEA Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
14.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Rest of MEA
14.2.2. By Product
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Analysis
15.1. The USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Product
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Product
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Product
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Product
15.4.2.2. By End User
15.5. France
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Product
15.5.2.2. By End User
15.6. Germany
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Product
15.6.2.2. By End User
15.7. Italy
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Product
15.7.2.2. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Product
15.8.2.2. By End User
15.9. The United Kingdom
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Product
15.9.2.2. By End User
15.10. Russia
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Product
15.10.2.2. By End User
15.11. Poland
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Product
15.11.2.2. By End User
15.12. Greater China
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Product
15.12.2.2. By End User
15.13. India
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Product
15.13.2.2. By End User
15.14. ANZ
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Product
15.14.2.2. By End User
15.15. Japan
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Product
15.15.2.2. By End User
15.16. GCC Countries
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Product
15.16.2.2. By End User
15.17. South Africa
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Product
15.17.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Mallinckrodt
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. GE Healthcare
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Bayer AG
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Ulrich GmbH & Co. KG
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Bracco Imaging S.p.A
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Medtron
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Nemoto Kyorindo Co. Ltd
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Shenzhen Anke High-tech Co. Ltd
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Sino Medical-Device Technology Co., Ltd.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. APOLLO RT Co. Ltd.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Value (US$ million) Forecast by Region, 2017 to 2033
Table 2: Global Volume (Units) Forecast by Region, 2017 to 2033
Table 3: Global Value (US$ million) Forecast by Product, 2017 to 2033
Table 4: Global Volume (Units) Forecast by Product, 2017 to 2033
Table 5: Global Value (US$ million) Forecast by End User, 2017 to 2033
Table 6: Global Volume (Units) Forecast by End User, 2017 to 2033
Table 7: North America Value (US$ million) Forecast by Country, 2017 to 2033
Table 8: North America Volume (Units) Forecast by Country, 2017 to 2033
Table 9: North America Value (US$ million) Forecast by Product, 2017 to 2033
Table 10: North America Volume (Units) Forecast by Product, 2017 to 2033
Table 11: North America Value (US$ million) Forecast by End User, 2017 to 2033
Table 12: North America Volume (Units) Forecast by End User, 2017 to 2033
Table 13: Latin America Value (US$ million) Forecast by Country, 2017 to 2033
Table 14: Latin America Volume (Units) Forecast by Country, 2017 to 2033
Table 15: Latin America Value (US$ million) Forecast by Product, 2017 to 2033
Table 16: Latin America Volume (Units) Forecast by Product, 2017 to 2033
Table 17: Latin America Value (US$ million) Forecast by End User, 2017 to 2033
Table 18: Latin America Volume (Units) Forecast by End User, 2017 to 2033
Table 19: Western Europe Value (US$ million) Forecast by Country, 2017 to 2033
Table 20: Western Europe Volume (Units) Forecast by Country, 2017 to 2033
Table 21: Western Europe Value (US$ million) Forecast by Product, 2017 to 2033
Table 22: Western Europe Volume (Units) Forecast by Product, 2017 to 2033
Table 23: Western Europe Value (US$ million) Forecast by End User, 2017 to 2033
Table 24: Western Europe Volume (Units) Forecast by End User, 2017 to 2033
Table 25: Eastern Europe Value (US$ million) Forecast by Country, 2017 to 2033
Table 26: Eastern Europe Volume (Units) Forecast by Country, 2017 to 2033
Table 27: Eastern Europe Value (US$ million) Forecast by Product, 2017 to 2033
Table 28: Eastern Europe Volume (Units) Forecast by Product, 2017 to 2033
Table 29: Eastern Europe Value (US$ million) Forecast by End User, 2017 to 2033
Table 30: Eastern Europe Volume (Units) Forecast by End User, 2017 to 2033
Table 31: APEJ Value (US$ million) Forecast by Country, 2017 to 2033
Table 32: APEJ Volume (Units) Forecast by Country, 2017 to 2033
Table 33: APEJ Value (US$ million) Forecast by Product, 2017 to 2033
Table 34: APEJ Volume (Units) Forecast by Product, 2017 to 2033
Table 35: APEJ Value (US$ million) Forecast by End User, 2017 to 2033
Table 36: APEJ Volume (Units) Forecast by End User, 2017 to 2033
Table 37: Japan Value (US$ million) Forecast by Country, 2017 to 2033
Table 38: Japan Volume (Units) Forecast by Country, 2017 to 2033
Table 39: Japan Value (US$ million) Forecast by Product, 2017 to 2033
Table 40: Japan Volume (Units) Forecast by Product, 2017 to 2033
Table 41: Japan Value (US$ million) Forecast by End User, 2017 to 2033
Table 42: Japan Volume (Units) Forecast by End User, 2017 to 2033
Table 43: MEA Value (US$ million) Forecast by Country, 2017 to 2033
Table 44: MEA Volume (Units) Forecast by Country, 2017 to 2033
Table 45: MEA Value (US$ million) Forecast by Product, 2017 to 2033
Table 46: MEA Volume (Units) Forecast by Product, 2017 to 2033
Table 47: MEA Value (US$ million) Forecast by End User, 2017 to 2033
Table 48: MEA Volume (Units) Forecast by End User, 2017 to 2033
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Value (US$ million) by Product, 2023 to 2033
Figure 2: Global Value (US$ million) by End User, 2023 to 2033
Figure 3: Global Value (US$ million) by Region, 2023 to 2033
Figure 4: Global Value (US$ million) Analysis by Region, 2017 to 2033
Figure 5: Global Volume (Units) Analysis by Region, 2017 to 2033
Figure 6: Global Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Value (US$ million) Analysis by Product, 2017 to 2033
Figure 9: Global Volume (Units) Analysis by Product, 2017 to 2033
Figure 10: Global Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 11: Global Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 12: Global Value (US$ million) Analysis by End User, 2017 to 2033
Figure 13: Global Volume (Units) Analysis by End User, 2017 to 2033
Figure 14: Global Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 15: Global Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 16: Global Attractiveness by Product, 2023 to 2033
Figure 17: Global Attractiveness by End User, 2023 to 2033
Figure 18: Global Attractiveness by Region, 2023 to 2033
Figure 19: North America Value (US$ million) by Product, 2023 to 2033
Figure 20: North America Value (US$ million) by End User, 2023 to 2033
Figure 21: North America Value (US$ million) by Country, 2023 to 2033
Figure 22: North America Value (US$ million) Analysis by Country, 2017 to 2033
Figure 23: North America Volume (Units) Analysis by Country, 2017 to 2033
Figure 24: North America Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 25: North America Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 26: North America Value (US$ million) Analysis by Product, 2017 to 2033
Figure 27: North America Volume (Units) Analysis by Product, 2017 to 2033
Figure 28: North America Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 29: North America Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 30: North America Value (US$ million) Analysis by End User, 2017 to 2033
Figure 31: North America Volume (Units) Analysis by End User, 2017 to 2033
Figure 32: North America Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 33: North America Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 34: North America Attractiveness by Product, 2023 to 2033
Figure 35: North America Attractiveness by End User, 2023 to 2033
Figure 36: North America Attractiveness by Country, 2023 to 2033
Figure 37: Latin America Value (US$ million) by Product, 2023 to 2033
Figure 38: Latin America Value (US$ million) by End User, 2023 to 2033
Figure 39: Latin America Value (US$ million) by Country, 2023 to 2033
Figure 40: Latin America Value (US$ million) Analysis by Country, 2017 to 2033
Figure 41: Latin America Volume (Units) Analysis by Country, 2017 to 2033
Figure 42: Latin America Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 43: Latin America Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 44: Latin America Value (US$ million) Analysis by Product, 2017 to 2033
Figure 45: Latin America Volume (Units) Analysis by Product, 2017 to 2033
Figure 46: Latin America Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 47: Latin America Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 48: Latin America Value (US$ million) Analysis by End User, 2017 to 2033
Figure 49: Latin America Volume (Units) Analysis by End User, 2017 to 2033
Figure 50: Latin America Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 51: Latin America Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 52: Latin America Attractiveness by Product, 2023 to 2033
Figure 53: Latin America Attractiveness by End User, 2023 to 2033
Figure 54: Latin America Attractiveness by Country, 2023 to 2033
Figure 55: Western Europe Value (US$ million) by Product, 2023 to 2033
Figure 56: Western Europe Value (US$ million) by End User, 2023 to 2033
Figure 57: Western Europe Value (US$ million) by Country, 2023 to 2033
Figure 58: Western Europe Value (US$ million) Analysis by Country, 2017 to 2033
Figure 59: Western Europe Volume (Units) Analysis by Country, 2017 to 2033
Figure 60: Western Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 61: Western Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 62: Western Europe Value (US$ million) Analysis by Product, 2017 to 2033
Figure 63: Western Europe Volume (Units) Analysis by Product, 2017 to 2033
Figure 64: Western Europe Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 65: Western Europe Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 66: Western Europe Value (US$ million) Analysis by End User, 2017 to 2033
Figure 67: Western Europe Volume (Units) Analysis by End User, 2017 to 2033
Figure 68: Western Europe Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 69: Western Europe Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 70: Western Europe Attractiveness by Product, 2023 to 2033
Figure 71: Western Europe Attractiveness by End User, 2023 to 2033
Figure 72: Western Europe Attractiveness by Country, 2023 to 2033
Figure 73: Eastern Europe Value (US$ million) by Product, 2023 to 2033
Figure 74: Eastern Europe Value (US$ million) by End User, 2023 to 2033
Figure 75: Eastern Europe Value (US$ million) by Country, 2023 to 2033
Figure 76: Eastern Europe Value (US$ million) Analysis by Country, 2017 to 2033
Figure 77: Eastern Europe Volume (Units) Analysis by Country, 2017 to 2033
Figure 78: Eastern Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 79: Eastern Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 80: Eastern Europe Value (US$ million) Analysis by Product, 2017 to 2033
Figure 81: Eastern Europe Volume (Units) Analysis by Product, 2017 to 2033
Figure 82: Eastern Europe Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 83: Eastern Europe Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 84: Eastern Europe Value (US$ million) Analysis by End User, 2017 to 2033
Figure 85: Eastern Europe Volume (Units) Analysis by End User, 2017 to 2033
Figure 86: Eastern Europe Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 87: Eastern Europe Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 88: Eastern Europe Attractiveness by Product, 2023 to 2033
Figure 89: Eastern Europe Attractiveness by End User, 2023 to 2033
Figure 90: Eastern Europe Attractiveness by Country, 2023 to 2033
Figure 91: APEJ Value (US$ million) by Product, 2023 to 2033
Figure 92: APEJ Value (US$ million) by End User, 2023 to 2033
Figure 93: APEJ Value (US$ million) by Country, 2023 to 2033
Figure 94: APEJ Value (US$ million) Analysis by Country, 2017 to 2033
Figure 95: APEJ Volume (Units) Analysis by Country, 2017 to 2033
Figure 96: APEJ Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 97: APEJ Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 98: APEJ Value (US$ million) Analysis by Product, 2017 to 2033
Figure 99: APEJ Volume (Units) Analysis by Product, 2017 to 2033
Figure 100: APEJ Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 101: APEJ Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 102: APEJ Value (US$ million) Analysis by End User, 2017 to 2033
Figure 103: APEJ Volume (Units) Analysis by End User, 2017 to 2033
Figure 104: APEJ Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 105: APEJ Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 106: APEJ Attractiveness by Product, 2023 to 2033
Figure 107: APEJ Attractiveness by End User, 2023 to 2033
Figure 108: APEJ Attractiveness by Country, 2023 to 2033
Figure 109: Japan Value (US$ million) by Product, 2023 to 2033
Figure 110: Japan Value (US$ million) by End User, 2023 to 2033
Figure 111: Japan Value (US$ million) by Country, 2023 to 2033
Figure 112: Japan Value (US$ million) Analysis by Country, 2017 to 2033
Figure 113: Japan Volume (Units) Analysis by Country, 2017 to 2033
Figure 114: Japan Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 115: Japan Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 116: Japan Value (US$ million) Analysis by Product, 2017 to 2033
Figure 117: Japan Volume (Units) Analysis by Product, 2017 to 2033
Figure 118: Japan Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 119: Japan Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 120: Japan Value (US$ million) Analysis by End User, 2017 to 2033
Figure 121: Japan Volume (Units) Analysis by End User, 2017 to 2033
Figure 122: Japan Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 123: Japan Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 124: Japan Attractiveness by Product, 2023 to 2033
Figure 125: Japan Attractiveness by End User, 2023 to 2033
Figure 126: Japan Attractiveness by Country, 2023 to 2033
Figure 127: MEA Value (US$ million) by Product, 2023 to 2033
Figure 128: MEA Value (US$ million) by End User, 2023 to 2033
Figure 129: MEA Value (US$ million) by Country, 2023 to 2033
Figure 130: MEA Value (US$ million) Analysis by Country, 2017 to 2033
Figure 131: MEA Volume (Units) Analysis by Country, 2017 to 2033
Figure 132: MEA Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 133: MEA Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 134: MEA Value (US$ million) Analysis by Product, 2017 to 2033
Figure 135: MEA Volume (Units) Analysis by Product, 2017 to 2033
Figure 136: MEA Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 137: MEA Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 138: MEA Value (US$ million) Analysis by End User, 2017 to 2033
Figure 139: MEA Volume (Units) Analysis by End User, 2017 to 2033
Figure 140: MEA Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 141: MEA Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 142: MEA Attractiveness by Product, 2023 to 2033
Figure 143: MEA Attractiveness by End User, 2023 to 2033
Figure 144: MEA Attractiveness by Country, 2023 to 2033
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
